Lindsay Harrison is an Endocrinology/Metabolic physician affiliated with Corning. OpenAlex indexes 24 publications with 2,114 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6500 N Mopac, Bldg 3, Ste 200
Austin, TX 787314309
Telephone
512-458-8400Registry record last updated 19 Jun 2014.
Industry payments
45 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202527 payments$22,923openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202512 payments
- BETA BIONICS, INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
41.3%GLP-1 receptor agonist17%Mounjaro54%Ozempic28%Trulicity16%Rybelsus2%Part D<11 patientsInsulin Analog9.3%Tresiba Flextouch U-10017%Toujeo Solostar14%Lantus Solostar14%Novolog Flexpen13%Toujeo Max Solostar11%Humalog Kwikpen U-10010%Humalog6%Tresiba Flextouch U-2006%Basaglar Kwikpen U-1004%Humalog Kwikpen U-2004%Fiasp Flextouch3%Part D<11 patients+ 6 more classes in this area
Hormonal (systemic)
32.8%l-Thyroxine26.6%Levothyroxine Sodium70%Synthroid25%Levoxyl4%Unithroid2%Part D<11 patientsl-Triiodothyronine2.7%Liothyronine Sodium100%Part D≥36 patients+ 4 more classes in this area
Cardiovascular
21.8%Statin11%Rosuvastatin Calcium66%Atorvastatin Calcium26%Pravastatin Sodium4%Simvastatin3%Part D<11 patientsCholesterol absorption inhibitor2.8%Ezetimibe100%Part D≥42 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”